Kidney disease

Causes

Causes of kidney disease include deposition of the Immunoglobulin A antibodies in the glomerulus, administration of analgesics, xanthine oxidase deficiency, toxicity of chemotherapy agents, and a long-term exposure to lead or its salts. Chronic conditions that can produce nephropathy include systemic lupus erythematosus, as well as diabetes mellitus and high blood pressure (hypertension), which lead to diabetic nephropathy and hypertensive nephropathy, respectively.

[[Autosomal dominant polycystic kidney disease]]

"Autosomal dominant polycystic kidney disease (ADPKD) is the most common genetic disease, affecting a half million Americans. The clinical phenotype can result from at least two different gene defects. One gene that can cause ADPKD has been located on the short arm of chromosome 16."

[[IgA nephropathy]]

Main article: IgA nephropathy

IgA nephropathy is the most common glomerulonephritis throughout the world Primary IgA nephropathy is characterized by deposition of the IgA antibody in the glomerulus. The classic presentation (in 40–50% of the cases) is episodic frank hematuria which usually starts within a day or two of a non-specific upper respiratory tract infection (hence synpharyngitic) as opposed to post-streptococcal glomerulonephritis which occurs some time (weeks) after initial infection. Less commonly gastrointestinal or urinary infection can be the inciting agent. All of these infections have in common the activation of mucosal defenses and hence IgA antibody production.

Polycystic disease of the kidneys

Main article: Polycystic kidney disease

Additional possible cause of nephropathy is due to the formation of cysts or pockets containing fluid within the kidneys. These cysts become enlarged with the progression of aging causing renal failure. Cysts may also form in other organs including the liver, brain, and ovaries. Polycystic kidney disease is a genetic disease caused by mutations in the PKD1, PKD2, and PKHD1 genes. This disease affects about half a million people in the US. Polycystic kidneys are susceptible to infections and cancer.

Xanthine oxidase deficiency

Main article: Xanthine oxidase deficiency

Another possible cause of Kidney disease is due to decreased function of xanthine oxidase in the purine degradation pathway. Xanthine oxidase will degrade hypoxanthine to xanthine and then to uric acid. Xanthine is not very soluble in water; therefore, an increase in xanthine forms crystals (which can lead to kidney stones) and result in damage to the kidney. Xanthine oxidase inhibitors, like allopurinol, can cause nephropathy.

Diabetes

Main article: Diabetic nephropathy

Diabetic nephropathy is a progressive kidney disease caused by angiopathy of the capillaries in the glomeruli. It is characterized by nephrotic syndrome and diffuse scarring of the glomeruli. It is particularly associated with poorly managed diabetes mellitus and is a primary reason for dialysis in many developed countries. It is classified as a small blood vessel complication of diabetes.

Lupus

Despite expensive treatments, lupus nephritis remains a major cause of morbidity and mortality in people with relapsing or refractory lupus nephritis.

COVID-19

COVID-19 is associated with kidney disease. In patients hospitalized with COVID-19, the prevalence of acute kidney injury is estimated to be 28%, and the prevalence of renal replacement therapy is estimated to be 9%.

Analgesics

Main article: Analgesic nephropathy

One cause of nephropathy is the long term usage of pain medications known as analgesics. The pain medicines which can cause kidney problems include aspirin, acetaminophen, and nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen and naproxen. This form of nephropathy is "chronic analgesic nephritis", a chronic inflammatory change characterized by loss and atrophy of tubules and interstitial fibrosis and inflammation (BRS Pathology, 2nd ed.).

Specifically, long-term use of the analgesic phenacetin has been linked to renal papillary necrosis (necrotizing papillitis).

Iodinated contrast media

Main article: Iodinated contrast media

Kidney disease induced by iodinated contrast media (ICM) is called contrast induced nephropathy (CIN) or contrast-induced acute kidney injury (AKI). Currently, the underlying mechanisms are unclear. But there is a body of evidence that several factors including apoptosis-induction seem to play a role.

Toxicity of chemotherapy agents

Main article: Onconephrology

Nephropathy can be associated with some therapies used to treat cancer. The most common form of kidney disease in cancer patients is acute kidney injury (AKI) which can usually be due to volume depletion from vomiting and diarrhea that occur following chemotherapy or occasionally due to kidney toxicities of chemotherapeutic agents. Kidney failure from break down of cancer cells, usually after chemotherapy, is unique to onconephrology. Several chemotherapeutic agents, for example cisplatin, are associated with acute and chronic kidney injuries. Newer agents such as anti-vascular endothelial growth factor (anti-VEGF) are also associated with similar injuries, as well as proteinuria, hypertension, and thrombotic microangiopathy.

Lithium

Main article: Lithium (medication)#Kidney damage

Lithium, a medication commonly used to treat bipolar disorder and schizoaffective disorders, can cause nephrogenic diabetes insipidus; its long-term use can lead to nephropathy. Long term lithium treatment is known to cause chronic kidney disease after 10-20 years of treatment in 1-5% of people. End-stage renal disease due to lithium occurs in 0.53% of people versus 0.2% in the general population. Dosing lithium more than once per day is associated with more kidney damage. Kidney harm can be mitigated by dosing lithium once per day at night and keeping the dose as low as possible. Dosing lithium once per day allows for long periods where the kidney is exposed to low levels of lithium, which minimizes kidney harm.

Anabolic-androgenic steroids

Regular and long-term use of anabolic-androgenic steroids (AAS) can cause both acute and chronic kidney disease through several direct and indirect mechanisms. Focal segmental glomerulosclerosis is the most common condition arising in such cases. Discontinuation of AAS in the early stage of Kidney Disease can result in a reversal of the kidney damage.

Diet

Higher dietary intake of animal protein, animal fat, and cholesterol may increase risk for microalbuminuria, a sign of kidney function decline, and generally, diets higher in fruits, vegetables, and whole grains but lower in meat and sweets may be protective against kidney function decline. This may be because sources of animal protein, animal fat, and cholesterol, and sweets are more acid-producing, while fruits, vegetables, legumes, and whole grains are more base-producing.

Diagnosis

The standard diagnostic workup of suspected kidney disease includes a medical history, physical examination, a urine test, and an ultrasound of the kidneys (renal ultrasonography). An ultrasound is essential in the diagnosis and management of kidney disease.

Treatment

Treatment approaches for kidney disease focus on managing the symptoms, controlling the progression, and also treating co-morbidities that a person may have.

Transplantation

Main article: Kidney transplantation

Millions of people across the world have kidney disease. Of those millions, several thousand will need dialysis or a kidney transplant at its end-stage. In the United States, as of 2008, 16,500 people needed a kidney transplant. Of those, 5,000 died while waiting for a transplant. Currently, there is a shortage of donors, and in 2007 there were only 64,606 kidney transplants in the world. This shortage of donors is causing countries to place monetary value on kidneys. Countries such as Iran and Singapore are eliminating their lists by paying their citizens to donate. Also, the black market accounts for 5–10 percent of transplants that occur worldwide. The act of buying an organ through the black market is illegal in the United States. To be put on the waiting list for a kidney transplant, patients must first be referred by a physician, then they must choose and contact a donor hospital. Once they choose a donor hospital, patients must then receive an evaluation to make sure they are sustainable to receive a transplant. In order to be a match for a kidney transplant, patients must match blood type and human leukocyte antigen factors with their donors. They must also have no reactions to the antibodies from the donor's kidneys.

Dialysis

Main article: Kidney dialysis

Because of the shortage of kidney donors, kidney dialysis is the most common method of renal replacement therapy for patients with kidney failure. Usually it is started at Stage 5 of chronic kidney failure, when the glomerular filtration rate is less than 15% of the normal.

For most patients, a kidney transplant offers a significant survival advantage and improved quality of life compared to remaining on dialysis, often adding years to life expectancy, though early risks exist, especially with certain donor types or in the elderly, but long-term outcomes favor transplant. Studies consistently show better long-term survival rates for transplant recipients, with one-year survival rates often above 90-95% for transplant, while dialysis patients face higher mortality.

Prognosis

Kidney disease can have serious consequences if it cannot be controlled effectively. Generally, the progression of kidney disease is from mild to serious. Some kidney diseases can cause kidney failure.

References

References

1. (2021). "Robbins & Coltran Pathologic Basis of Disease". Elsevier.
2. "Kidney Disease: Fact Sheet {{!}} National Kidney Foundation".
3. "Patient education: Glomerular disease (Beyond the Basics), UpToDate".
4. "Definition and staging of chronic kidney disease in adults, UpToDate".
5. (2008-06-28). "Chronic kidney disease in Asia". The Lancet.
6. (2010-04-10). "Early recognition and prevention of chronic kidney disease". The Lancet.
7. "The top 10 causes of death".
8. (2007-11-07). "Prevalence of chronic kidney disease in the United States". JAMA.
9. (2024-05-15). "Chronic Kidney Disease in the United States, 2023".
10. "Polycystic Kidney Disease, Autosomal Dominant".
11. (1 November 1990). "Autosomal Dominant Polycystic Kidney Disease – More Than a Renal Disease". American Journal of Kidney Diseases.
12. D'Amico, G. (1987). "The commonest glomerulonephritis in the world: IgA nephropathy.". Q J Med.
13. Longo et al., ''Harrison's Principles of Internal Medicine'', 18th ed., p. 2982
14. (2012-12-01). "Lupus nephritis: a critical review". Autoimmunity Reviews.
15. (2020-12-08). "The Prevalence of Acute Kidney Injury in Patients Hospitalized With COVID-19 Infection: A Systematic Review and Meta-analysis". Kidney Medicine.
16. (2006). "Role of Apoptosis in the Pathogenesis of Contrast Media-induced Nephropathy and Hints for its Possible Prevention by Drug Treatment". Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry.
17. Portilla D, Safar AM, Shannon ML, Penson RT. "Cisplatin nephrotoxicity". In: UpToDate, Palevsky PM (Ed), UpToDate, Waltham, MA, 2013. http://www.uptodate.com/contents/cisplatin-nephrotoxicity
18. Robinson, Emily S.. (1 November 2010). "Hypertension Induced by Vascular Endothelial Growth Factor Signaling Pathway Inhibition: Mechanisms and Potential Use as a Biomarker". Seminars in Nephrology.
19. (May 2009). "Lithium nephrotoxicity revisited". Nat Rev Nephrol.
20. (2012-03-01). "The science and practice of lithium therapy". Australian & New Zealand Journal of Psychiatry.
21. (2019-07-22). "Clinical use of lithium salts: guide for users and prescribers". International Journal of Bipolar Disorders.
22. (August 2003). "Lithium-induced nephropathy: Rate of progression and prognostic factors". Kidney International.
23. (2017-08-01). "Long-term lithium treatment in bipolar disorder: effects on glomerular filtration rate and other metabolic parameters". International Journal of Bipolar Disorders.
24. (2020). "When and how to use lithium". Acta Psychiatrica Scandinavica.
25. (2013-10-01). "An Updated Review of the Optimal Lithium Dosage Regimen for Renal Protection". The Canadian Journal of Psychiatry.
26. MD, Chris Aiken. (2026-01-19). "6 Ways to Protect the Kidneys While Prescribing Lithium {{!}} Psychiatric Times".
27. (2020). "When and how to use lithium". Acta Psychiatrica Scandinavica.
28. (January 2020). "Kidney disease associated with androgenic–anabolic steroids and vitamin supplements abuse: Be aware!". Nefrología.
29. (December 2019). "The potential effects of anabolic-androgenic steroids and growth hormone as commonly used sport supplements on the kidney: a systematic review". BMC Nephrology.
30. (2009-12-10). "Weightlifters Bulking Up With Anabolic Steroids Also Do Serious Harm To Kidneys".
31. "Bodybuilding With Steroids Damages Kidneys".
32. Ireland, Rebecca. (March 2010). "Anabolic steroid abuse can lead to focal segmental glomerulosclerosis". Nature Reviews Nephrology.
33. (December 2019). "The potential effects of anabolic-androgenic steroids and growth hormone as commonly used sport supplements on the kidney: a systematic review". BMC Nephrology.
34. "Using steroids to bulk up? Watch for kidney damage". Reuters.
35. (2010-05-01). "Associations of diet with albuminuria and kidney function decline". Clinical Journal of the American Society of Nephrology.
36. (2011-02-01). "Association of dietary patterns with albuminuria and kidney function decline in older white women: a subgroup analysis from the Nurses' Health Study". American Journal of Kidney Diseases.
37. (2014-01-01). "Metabolic acidosis and the progression of chronic kidney disease". BMC Nephrology.
38. (2002-12-01). "Estimation of the net acid load of the diet of ancestral preagricultural Homo sapiens and their hominid ancestors". The American Journal of Clinical Nutrition.
39. (2011-02-01). "Dietary acid load and rapid progression to end-stage renal disease of diabetic nephropathy in Westernized South Asian people". Journal of Nephrology.
40. (1982-09-09). "Dietary protein intake and the progressive nature of kidney disease: the role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease". The New England Journal of Medicine.
41. (2014-01-01). "Is dietary Acid a modifiable risk factor for nephropathy progression?". American Journal of Nephrology.
42. (2011-07-01). "Estimated net endogenous acid production and serum bicarbonate in African Americans with chronic kidney disease". Clinical Journal of the American Society of Nephrology.
43. (2014-01-01). "Dietary acid intake and kidney disease progression in the elderly". American Journal of Nephrology.
44. (2014-01-01). "Dietary acid load and chronic kidney disease among adults in the United States". BMC Nephrology.
45. (2013-03-01). "A comparison of treating metabolic acidosis in CKD stage 4 hypertensive kidney disease with fruits and vegetables or sodium bicarbonate". Clinical Journal of the American Society of Nephrology.
46. (2010-03-01). "Nutrient based estimation of acid-base balance in vegetarians and non-vegetarians". Plant Foods for Human Nutrition (Dordrecht, Netherlands).
47. (2015-12-23). "Ultrasonography of the Kidney: A Pictorial Review". Diagnostics.
48. (2016-06-28). "Acupuncture and related interventions for symptoms of chronic kidney disease". The Cochrane Database of Systematic Reviews.
49. (January 8, 2010). "The Meat Market". Wall Street Journal.
50. (7 May 2008). "How Organ Donations Work". HowStuffWorks.
51. "The Waiting List".
52. "Top 5 reasons to refer a patient early for kidney transplant - Mayo Clinic".
53. "Statistics {{!}} The Kidney Project".
54. (October 2023). "Survival after kidney transplantation compared with ongoing dialysis for people over 70 years of age: A matched-pair analysis". American Journal of Transplantation.